Erectile Aid Use in Post-phalloplasty and Post-metoidioplasty Transgender Patients
Launched by UNIVERSITY HOSPITAL, GHENT · Oct 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how transgender men use different aids to help with sexual intercourse after undergoing surgeries called phalloplasty or metoidioplasty, which are procedures that create a penis. The researchers want to understand how satisfied these men are with various types of erectile aids, as well as how their partners feel about them. While some patients choose surgical options, they can have complications, so many look for non-surgical aids. This study aims to gather information on what aids are being used, how well they work, and the satisfaction levels of both the users and their partners.
To participate in the trial, individuals must be at least 18 years old and have had either phalloplasty or metoidioplasty at least six months ago. They should also be sexually active since their surgery. The study is currently recruiting participants, and those involved will share their experiences to help improve understanding and support for future patients. This research is important as it will provide valuable insights for healthcare providers and help enhance the quality of care for transgender individuals seeking sexual health support.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patient and partner age ≥ 18 years.
- • Transgender or gender non-conforming individuals (and their partners).
- • Patients have undergone phalloplasty or metoidioplasty as a form of genital gender affirming surgery.
- • ≥6 months after phalloplasty or metoidioplasty (any type of flap or technique is allowed).
- • Sexually active or has been sexually active since phalloplasty or metoidioplasty with a partner or main sexual partner.
- • Voluntarily agreed that the data may be used for an anonymized scientific study.
- Exclusion Criteria:
- • Patient age \< 18 years.
- • Cisgender patients treated with phalloplasty or metoidioplasty for various reasons.
- • \<6 months after phalloplasty or metoidioplasty.
- • Not sexually active since phalloplasty/metoidioplasty.
- • Patient and/or partner have no interest in penetrative sexual intercourse.
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, East Flanders, Belgium
Patients applied
Trial Officials
Anne-Françoise Spinoit, MD, PhD
Principal Investigator
University Hospital, Ghent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported